MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jgh.70003

Медицинская библиотека · Journal of gastroenterology and hepatology · 2025

Impact of Renin-Angiotensin-Aldosterone System Inhibitors on Liver-Related Events and Mortality in Patients With Cirrhosis: A Meta-Analysis of Real-World Evidence.

Chen Yuenan, Zhai Dongqing, Shen Jinhai, Hu Weiwei

СтатьяМетаанализСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

The therapeutic implications of renin-angiotensin-aldosterone system inhibitors (RAASi) in modulating liver-related events (LREs) and mortality among patients with cirrhosis remain clinically uncertain. This meta-analysis synthesizes real-world evidence to clarify the association between RAASi use and clinical outcomes in this population.

METHODS

We conducted a systematic literature search across PubMed, Embase, and Web of Science through December 25, 2024. Studies comparing LREs incidence or overall survival (OS) between patients with cirrhosis receiving RAASi versus non-users were eligible. Pooled hazard ratios (HR) with 95% confidence intervals (CI) were calculated to obtain an overall estimate.

RESULTS

Seven studies comprising nine cohorts (N = 22 736) met inclusion criteria. RAASi use demonstrated a modest but significant reduction in LREs risk (HR, 0.81; 95% CI, 0.66-1.00; p = 0.0493) and significantly improved OS (HR, 0.73; 95% CI, 0.66-0.81; p < 0.0001). Subgroup analysis revealed particular benefit in hepatocellular carcinoma (HCC) prevention (HR, 0.88; 95% CI, 0.78-0.99; p = 0.0306).

CONCLUSION

This meta-analysis suggests RAASi therapy may confer dual hepatoprotective and survival benefits in patients with cirrhosis, particularly regarding HCC prevention. While real-world evidence indicates favorable risk reduction profiles, these findings warrant validation through prospective randomized trials to establish causality and optimize therapeutic protocols. Clinicians should consider individualized risk-benefit assessments when prescribing RAASi in this vulnerable population.

Для цитирования: Chen Yuenan, Zhai Dongqing, Shen Jinhai, Hu Weiwei. Impact of Renin-Angiotensin-Aldosterone System Inhibitors on Liver-Related Events and Mortality in Patients With Cirrhosis: A Meta-Analysis of Real-World Evidence.. Journal of gastroenterology and hepatology. 2025. DOI: 10.1111/jgh.70003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.